Literature DB >> 30849449

ERAP1 shapes just part of the immunopeptidome.

Arie Admon1.   

Abstract

ERAP1 is an aminopeptidase involved in trimming long peptides to the lengths required for presentation by MHC class I. ERAP1 substrate preference is for peptides with hydrophobic or aliphatic N-terminal amino acids, with lower efficacy with charged and small hydrophilic amino acids and almost complete inefficiency with proline. Since ERAP1 efficiently trims peptides to eight amino acids or even shorter, and many MHC-I allotypes can only bind peptides that are eight or nine amino acids or longer, ERAP1 both produces and destroys potential ligands of these alleles. The observation that ERAP1 modulates the levels of presentation for only a subset of the immunopeptidome conflicts with the common assumption that most MHC-I peptides are derived from longer peptides that are produced by the proteasome, transported into the endoplasmic reticulum (ER) by the Transporter Associated Peptide Presentation (TAP) and then trimmed by ERAP1. A more likely mechanism is that cellular protein degradation produces surplus amounts of peptides that fit perfectly and are rapidly loaded onto the MHC, with only a minority of peptides requiring trimming within the ER before loading. Alternatively, ERAP1 may not be present in all ER compartments or vesicles where peptide processing and loading take place and thus affects just a subset of the immunopeptidome.
Copyright © 2019 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ERAP1; HLA; Immunopeptidome; MHC; Peptidome

Mesh:

Substances:

Year:  2019        PMID: 30849449     DOI: 10.1016/j.humimm.2019.03.004

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  9 in total

1.  Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome.

Authors:  Pablo Guasp; Elena Lorente; Adrian Martín-Esteban; Eilon Barnea; Paolo Romania; Doriana Fruci; JonasJ W Kuiper; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2019-05-15       Impact factor: 5.911

2.  A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1.

Authors:  George Mavridis; Richa Arya; Alexander Domnick; Jerome Zoidakis; Manousos Makridakis; Antonia Vlahou; Anastasia Mpakali; Angelos Lelis; Dimitris Georgiadis; Robert Tampé; Athanasios Papakyriakou; Lawrence J Stern; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2020-03-17       Impact factor: 5.157

Review 3.  microRNA, a Subtle Indicator of Human Cytomegalovirus against Host Immune Cells.

Authors:  Mengyao Yu; Yuexinzi Jin; Shichang Zhang; Jian Xu; Jiexin Zhang
Journal:  Vaccines (Basel)       Date:  2022-01-19

4.  HLA-B27 may modulate the interaction between ERAP1 polymorphisms and smoking in ankylosing spondylitis patients.

Authors:  Javier Fernández-Torres; Yessica Zamudio-Cuevas; Nathalie Montaño-Armendariz; Iván Alejandro Luján-Juárez; Roberto Sánchez-Sánchez; Karina Martínez-Flores
Journal:  Mol Biol Rep       Date:  2022-04-16       Impact factor: 2.742

Review 5.  To Be or Not to Be: The Case of Endoplasmic Reticulum Aminopeptidase 2.

Authors:  Piotr Kuśnierczyk
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

6.  Genome-wide association study of SARS-CoV-2 infection in Chinese population.

Authors:  Jie Fan; Quan-Xin Long; Ji-Hua Ren; Hao Chen; Meng-Meng Li; Zheng Cheng; Juan Chen; Li Zhou; Ai-Long Huang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-08-04       Impact factor: 5.103

7.  Polymorphisms of Antigen-Presenting Machinery Genes in Non-Small Cell Lung Cancer: Different Impact on Disease Risk and Clinical Parameters in Smokers and Never-Smokers.

Authors:  Andrzej Wiśniewski; Maciej Sobczyński; Konrad Pawełczyk; Irena Porębska; Monika Jasek; Marta Wagner; Wanda Niepiekło-Miniewska; Aneta Kowal; Joanna Dubis; Natalia Jędruchniewicz; Piotr Kuśnierczyk
Journal:  Front Immunol       Date:  2021-05-31       Impact factor: 7.561

8.  Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands.

Authors:  Marta A S Perez; Michal Bassani-Sternberg; George Coukos; David Gfeller; Vincent Zoete
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

9.  Common allotypes of ER aminopeptidase 1 have substrate-dependent and highly variable enzymatic properties.

Authors:  Jonathan P Hutchinson; Ioannis Temponeras; Jonas Kuiper; Adrian Cortes; Justyna Korczynska; Semra Kitchen; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2021-02-19       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.